conv.

← The whole story
Health
KFF analysis: Hundreds of FDA-ordered postmarket drug studies delayed or incomplete

Researchers warn faster pre-approval testing will increase reliance on weak postmarket oversight

1 Sep 18 5:00 AM · 5d ago · 5 articles · 1 post · 2 sources · development 1 of 1

Medical researchers warn that Trump administration policies reducing pre-approval testing will put more pressure on the postmarket system, which is already plagued by delays and enforcement failures. The shift risks exposing patients to drugs that may cause more harm than benefit.

Researchers warn faster pre-approval testing will increase reliance on weak postmarket oversight
kffhealthnews.org

“Reducing pre-approval testing "will inevitably put a lot of pressure on the post-approval system,"”

Aaron Kesselheim, professor of medicine, Harvard Medical School

Sanket Dhruva Cardiologist and medicine professor, UC San FranciscoAaron Kesselheim Medicine professor, Harvard Medical SchoolFDA Regulator approving drugs and setting postmarket study requirementsDepartment of Health and Human Services Federal agency overseeing FDA

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 3 pieces in two hours at Yesterday, 6 AM; 6 pieces over 6 days (5 articles · 1 post) Sep 18, 4 AM — 1 piece · 1 article — Newswires 1Sep 18, 6 AM — quietSep 18, 8 AM — 1 piece · 1 article — Newswires 1Sep 18, 10 AM — quietSep 18, 12 PM — quietSep 18, 2 PM — quietSep 18, 4 PM — quietSep 18, 6 PM — quietSep 18, 8 PM — quietSep 18, 10 PM — quietSep 19, 12 AM — quietSep 19, 2 AM — quietSep 19, 4 AM — quietSep 19, 6 AM — quietSep 19, 8 AM — quietSep 19, 10 AM — quietSep 19, 12 PM — quietSep 19, 2 PM — quietSep 19, 4 PM — quietSep 19, 6 PM — quietSep 19, 8 PM — quietSep 19, 10 PM — quietSep 20, 12 AM — quietSep 20, 2 AM — quietSep 20, 4 AM — quietSep 20, 6 AM — quietSep 20, 8 AM — quietSep 20, 10 AM — quietSep 20, 12 PM — quietSep 20, 2 PM — quietSep 20, 4 PM — 1 piece · 1 post — Mastodon 1Sep 20, 6 PM — quietSep 20, 8 PM — quietSep 20, 10 PM — quietSep 21, 12 AM — quietSep 21, 2 AM — quietSep 21, 4 AM — quietSep 21, 6 AM — quietSep 21, 8 AM — quietSep 21, 10 AM — quietSep 21, 12 PM — quietSep 21, 2 PM — quietSep 21, 4 PM — quietSep 21, 6 PM — quietSep 21, 8 PM — quietSep 21, 10 PM — quietSep 22, 12 AM — quietSep 22, 2 AM — quietSep 22, 4 AM — quietSep 22, 6 AM — quietSep 22, 8 AM — quietSep 22, 10 AM — quietSep 22, 12 PM — quietSep 22, 2 PM — quietSep 22, 4 PM — quietSep 22, 6 PM — quietSep 22, 8 PM — quietSep 22, 10 PM — quietYesterday, 12 AM — quietYesterday, 2 AM — quietYesterday, 4 AM — quietYesterday, 6 AM — 3 pieces · 3 articles — Newswires 3Yesterday, 8 AM — quietYesterday, 10 AM — quietYesterday, 12 PM — quietYesterday, 2 PM — quietYesterday, 4 PM — quietYesterday, 6 PM — quietYesterday, 8 PM — quietYesterday, 10 PM — quietToday, 12 AM — quietToday, 2 AM — quiet 1
1Researchers warn faster pre-approval…
Sep 19Sep 20Sep 21Sep 22yesterdaynow · 3:51 AM ET

Reported in the same hours no headline names this development itself — these 1 claim were published in its stretch

  1. 5 outlets The FDA requires follow-up studies for drugs and devices. Years later, many still aren’t done

    first by GovExec, 5d ago · also Orlando Sentinel, Mercury News, Baltimore Sun, KFF Health News

    1 more headline

What people said 1 voice · verbatim

All 1 developments of KFF analysis: Hundreds of FDA-ordered postmarket drug… →

NewswiresMastodon